The Management of Hypertension in the Overweight and Obese Patient: Is Weight Reduction Sufficient?

ISSN： 0012-6667

Source： Drugs, Vol.64, Iss.11, 2004-01, pp. : 1263-1263

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Management of Hypertension in the Overweight and Obese Patient: Is Weight Reduction Sufficient?

By Douketis J.D. Sharma A.M.

Drugs, Vol. 64, Iss. 8, 2004-01 ,pp. : 795-803

Adis International

Access to resources Recommend Favorite

Pharmacokinetic Model-Driven Remifentanil Administration in the Morbidly Obese: The `Critical Weight' and the `Fictitious Height', a Possible Solution to an Unsolved Problem?

By Colla L. La

Clinical Pharmacokinetics, Vol. 48, Iss. 6, 2009-06 ,pp. : 397-398

Adis International

Access to resources Recommend Favorite

The Cost Effectiveness of Orlistat in a 1-Year Weight-Management Programme for Treating Overweight and Obese Patients in Sweden: A Treatment Responder Approach

By Hertzman Peter

PharmacoEconomics, Vol. 23, Iss. 10, 2005-01 ,pp. : 1007-1020

Adis International

Access to resources Recommend Favorite

Bevacizumab and hypertension: a Catch-22?

Reactions Weekly, Vol. 1, Iss. 1292, 2010-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Gene therapy for pulmonary hypertension?

Inpharma, Vol. 1, Iss. 1231, 2000-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite